<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05611294</url>
  </required_header>
  <id_info>
    <org_study_id>HDRR-CON2022</org_study_id>
    <nct_id>NCT05611294</nct_id>
  </id_info>
  <brief_title>Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction</brief_title>
  <official_title>A Visual Outcome Comparison of Topography Guided LASIK Versus Small Incision Lenticule Extraction: A Prospective Contralateral Eye Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hoopes Vision</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hoopes Vision</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates differences in postoperative visual outcomes between patients receiving&#xD;
      Topography-Guided LASIK in one eye and Small Incision Lenticule Extraction in the other eye.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, simultaneous, contralateral eye study including at least&#xD;
      42 patients undergoing refractive correction surgery. Patients will be selected from the&#xD;
      Hoopes Vision patient population after a preliminary refractive evaluation has been&#xD;
      completed. Patients who express an interest in the study will be consented. After informed&#xD;
      consent has been obtained and the patient has completed a screening exam and met all study&#xD;
      criteria they will be considered enrolled. Randomization will ensure 50% of Right Eyes will&#xD;
      receive Topography-Guided LASIK and 50% of Right Eyes will receive Small Incision Lenticule&#xD;
      Extraction. Subjects will be given postoperative care instructions and medications following&#xD;
      standard of care practices. Subjects will return for a 1-day, 1-week, 1-month, 3-month, and&#xD;
      12-month visit. Retreatments may only occur after all postoperative study visits have been&#xD;
      completed and/or the subject has exited the study. At the preliminary screening visit,&#xD;
      1-month, 3-month, and 12-mont postoperative visits, patients will complete a Patient&#xD;
      Participant Questionnaire.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 27, 2022</start_date>
  <completion_date type="Anticipated">August 11, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 11, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Contralateral Eye to Eye Comparison</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uncorrected Visual Acuity</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of eyes with Uncorrected Visual Acuity of 20/20 or better</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corrected Visual Acuity</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of eyes with Corrected Visual Acuity of 20/20 or better</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictability of Intended Outcome</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of eyes with refractive error within +/- 0.50 D MRSE and +/- 1.00 D MRSE of intended correction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Myopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Topography-Guided LASIK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects receive Topography-Guided LASIK surgery on one eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Small Incision Lenticule Extraction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects receive Small Incision Lenticule Extraction surgery on one eye.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Topography Guided LASIK Surgery</intervention_name>
    <description>LASIK surgery, using corneal topography data in treatment profile, to correct myopia or myopia with astigmatism refractive error.</description>
    <arm_group_label>Topography-Guided LASIK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Small Incision Lenticule Extraction Surgery</intervention_name>
    <description>Corneal lenticule formation using a femtosecond laser, with subsequent lenticule extraction, to correct myopia or myopia with astigmatism refractive error.</description>
    <arm_group_label>Small Incision Lenticule Extraction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 22-50 at the time of consent&#xD;
&#xD;
          2. Diagnosis of myopia or myopia with astigmatism with Preop manifest spherical&#xD;
             equivalent of refraction of ≥ -2.00 and ≤ -9.00 D&#xD;
&#xD;
          3. Preop Spherical component of ≥ -2.00 and ≤ -8.00 D&#xD;
&#xD;
          4. Refractive Cylinder of ≤ -3.00 D&#xD;
&#xD;
          5. BCVA of 20/20 or better in each eye&#xD;
&#xD;
          6. Subjects must have a stable refraction which is defined as change in spherical&#xD;
             equivalent no greater than 0.50 D comparing screening visit manifest refraction to&#xD;
             previous refractions over one year period prior to surgery. (spectacle Rx, or contact&#xD;
             lens Rx)&#xD;
&#xD;
          7. Subjects who are contact lens wearers must have hard or gas permeable lenses&#xD;
             discontinued for at least 4 weeks and soft lenses discontinued for at least 5 days&#xD;
             prior to the preoperative screening evaluation. Hard or gas permeable lens wearers&#xD;
             must not return to contact lens use before surgery and soft lens wearers must&#xD;
             discontinue use at least 5 days before surgery.&#xD;
&#xD;
          8. Acceptable topography and baseline examination results for refractive procedures as&#xD;
             determined by Principal Investigator or Co-Investigator&#xD;
&#xD;
          9. Surgical plan includes treatment target for emmetropia in both eyes and no monovision.&#xD;
&#xD;
         10. Subject is capable and willing to use postoperative medications as prescribed.&#xD;
&#xD;
         11. Subject has ability to successfully complete all preoperative and postoperative&#xD;
             questionnaires, testing, and exam visits.&#xD;
&#xD;
         12. Subjects are willing and able to return for all postoperative examinations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Clinically significant dry eye on clinical examination as determined by the&#xD;
             investigator&#xD;
&#xD;
          2. Irregular astigmatism, keratoconus, keratoconus suspect, or abnormal corneal&#xD;
             topography&#xD;
&#xD;
          3. History of corneal dystrophies or guttata&#xD;
&#xD;
          4. History of herpetic keratitis or active disease&#xD;
&#xD;
          5. History of prior refractive surgery&#xD;
&#xD;
          6. History of glaucoma or glaucoma suspect&#xD;
&#xD;
          7. History of uncontrolled diabetes, unstable hypertension, or unstable autoimmune&#xD;
             disease.&#xD;
&#xD;
          8. Females who are pregnant, breast-feeding, or intend to become pregnant any time during&#xD;
             the course of the study as determined by verbal inquiry.&#xD;
&#xD;
          9. The Principal Investigator has determined the subject not to be a good candidate for&#xD;
             the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Majid Moshirfar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hoopes Vision</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven H Linn, OD</last_name>
    <phone>801-568-0200</phone>
    <email>slinn@hoopesvision.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michele R Avila, OD</last_name>
    <phone>801-568-0200</phone>
    <email>mavila@hoopesvision.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hoopes Vision</name>
      <address>
        <city>Draper</city>
        <state>Utah</state>
        <zip>84020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven H Linn, OD</last_name>
      <phone>801-568-0200</phone>
      <email>slinn@hoopesvision.com</email>
    </contact>
    <contact_backup>
      <last_name>Michele R Avila, OD</last_name>
      <phone>801-568-0200</phone>
      <email>mavila@hoopesvision.com</email>
    </contact_backup>
    <investigator>
      <last_name>Majid Moshirfar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>October 27, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2022</study_first_posted>
  <last_update_submitted>November 7, 2022</last_update_submitted>
  <last_update_submitted_qc>November 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>refractive surgery</keyword>
  <keyword>myopia</keyword>
  <keyword>astigmatism</keyword>
  <keyword>excimer laser</keyword>
  <keyword>femtosecond laser</keyword>
  <keyword>VARIO Topolyzer</keyword>
  <keyword>Lenticule</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No individual participant data will be shared with other researchers outside of those participating in this specific study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

